Abstract
The attention to transgender medicine has changed over the last decade and the interest is most likely going to increase in the future due to the fact that gender-affirming treatments are now being requested by an increasing number of transgender people. Even if gender-affirming hormone therapy (GAHT) is based on a multidisciplinary approach, this review is going to focus on the procedures adopted by the endocrinologist in an out-clinic setting once an adult patient is referred by another specialist for ‘gender affirming’ therapy. Before commencing this latter treatment, several background information on unmet needs regarding medical and surgical outcomes should be investigated. We summarized our endocrinological clinical and therapeutic approaches to adult transgender individuals before and during GAHT based on a non-systematic review. Moreover, the possible relationships between GAHT, gender-related pharmacology, and COVID-19 are also reported.
Highlights
Over the past 10 years, awareness about transgender medicine has increased
Based on fulfillment of diagnostic criteria by prior health-care professionals (HCPs)’s evaluations, we aimed to describe the role of the endocrinologist in the management of the different gender‐affirming treatment options and of clinical monitoring in transgender adults in our multidisciplinary single‐center medical clinic dedicated to outpatients
Gender dysphoria should be managed by a multidisciplinary team of well experienced physicians, including endocrinologists, psychiatrists, gynecologists/urologists, and surgeons
Summary
Gender identity refers to “a person’s deeply-felt, inherent sense of being a boy, a man, or a male, a girl, a woman, or a female, or an alternative gender (e.g., genderqueer, gender nonconforming, gender neutral) that may or may not correspond to a person’s gender assigned at birth or to a person’s primary or secondary sex characteristics” [1] In this narrative review, we shall focus our attention on the endocrine clinical and therapeutic approach of people experiencing Gender Dysphoria (GD) as defined by a distress due to “a marked incongruence between a person’s gender assigned at birth and gender identity” [2]. Based on fulfillment of diagnostic criteria by prior HCP’s evaluations, we aimed to describe the role of the endocrinologist in the management of the different gender‐affirming treatment options and of clinical monitoring in transgender adults in our multidisciplinary single‐center medical clinic dedicated to outpatients.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
